Lakefront Biotherapeutics Gains FDA Orphan Status for Gamgertamig
MECHELEN, Belgium — August 24, 2026 Lakefront Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...
ITP
Advertisement
Sanofi Wins Japan Approval for Wayrilz in Rare Blood Disease
PARIS, June 23, 2026 Sanofi has secured an important regulatory milestone after Japan’s Ministry of Health, Labour and Welfare...
UCB and Biogen Report Positive Phase 3 Lupus Results for Dapirolizumab Pegol in The Lancet
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 1, 2026 UCB and Biogen announced the publication of full Phase 3 PHOENYCS...
Agios Expands Rare Hematology Portfolio with Global Cevidoplenib Licensing Deal
CAMBRIDGE, Mass., June 1, 2026 Agios Pharmaceuticals has entered an exclusive global licensing agreement with South Korea-based Oscotec to...
InnoCare Wins China NDA Acceptance for Orelabrutinib in ITP
BEIJING — May 28, 2026 InnoCare Pharma announced that China’s Center for Drug Evaluation (CDE) under the National Medical...
Advertisement
